B.S., University of Minnesota
M.S. Cornell University
Undertaking the National Key R&D Program - Disruptive Innovation Project
During the tenure at Boston Scientific Minnesota R&D Center, established the first AI R&D team to support global factories
B.S., University of Minnesota
M.S, Duke University
Previously worked at the Liberty Mutual, led the first legal AI application within the group
During the tenure at Boston Scientific Minnesota R&D Center, established the first AI R&D team to support global factories
Resident office in the United States (Harvard Medical School affiliated incubator)
Harvard Business School | MBA
Ex-BCG, Mars, Alibaba, Amazon; Ex-executive at Harvard-based startup
9+ yrs in consumer goods, cross-boarder ecommerce and consulting
Doctor of Clinical Medicine, Xiangya Medical College, Central South University
Master of Global Health Economics, Johns Hopkins University, USA
Previously worked in the WHO Chronic Disease Management Department, a multinational pharmaceutical consulting company, and published multiple SCI academic papers
Previously worked at a well-known domestic venture capital firm, focusing on and specializing in investing in innovative pharmaceutical companies from a clinical needs perspective. Skilled in incubation, operation, and capitalization management of innovative technology enterprises
B.S., Shandong University
Peking University | MBA
Product development lead
Ex-CEO, Leading Micros, 10+ yrs in corporate management
Ph.D., Biomedical Science
University of Giessen M.S., Northwest A&F University,B.S., Zhengzhou University
Medical Device Registration Expert,GMP & Quality System Leadership
Full-Cycle Operation from 0 to 1
The team has served with Boston Scientific, the World Health Organization (WHO), Johns Hopkins University, Johnson&Johnson IBM、 McKinsey, Yifeng Capital and other institutions
Strategically planned and executed with precision, we have accumulated cross-border experience covering global medical policies, clinical practices, industrial investment, and consumer technology, enabling us to switch between "strategic height" and "execution on the ground".